The Chelsea Collection Inc. Welcomes Baby Boomers; Chelsea Collection Inc. G-H-3-Plus Proven Anti-Aging Protocol Big Boost to Boomers.LAS VEGAS Las Vegas (läs vā`gəs), city (1990 pop. 258,295), seat of Clark co., S Nev.; inc. 1911. It is the largest city in Nevada and the center of one of the fastest-growing urban areas in the United States. -- The Chelsea Collection The Chelsea Collection is a priceless anthology of prints and pictures of old Chelsea. Begun in 1887, it contains works by artists as notable and diverse as Rossetti and Whistler. (Pink Sheets:CLSN CLSN Claystone (lithological term) ), announced that the Company now has a proven medical protocol available to address the issues of aging and vitality for the 78 million plus baby boomers See generation X. in the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. . Boomers' spent over $50 billion dollars last year on anti-aging services, cosmetic oriented products, and supplements to keep them looking and feeling young, vibrant and healthy. The authorized clinic to offer the G-H-3 Plus(R) protocol is Kozmary Center for Pain Management in Las Vegas. "The company is very excited that we can now offer the G-H-3 Plus(R) protocol in America," said Flo Ternes, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "This will allow baby boomers and others who are concerned about the effects of aging and disease to utilize this proven and effective treatment without the expense and hassle of traveling to another country." Up until now, the G-H-3 Plus(R) protocol, developed by world renowned geriatric doctor and researcher Dr. Ana Aslan, has only been available in European clinics. The Company is in the process of finalizing its marketing plan and anticipates bringing the therapy to the general public in September. For more information, visit http://www.gh3international.com DISCLAIMER This document contains 'forward looking statements' concerning CLSN operations and strategies, including its future economic performance, intent, plans, objectives and the likelihood of success in developing and expanding the business. These statements are based upon assumptions and estimates that are subject to significant uncertainties, many of which are beyond CLSN's control. Words such as "may," "would," "could," "will," "expect," "anticipate," "intend," "plan," and "estimate," are meant to identify such forward looking statements. Actual results may differ materially from those expressed or implied by such forward-looking statements. The company assumes no obligation to update this information. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion